미국의 차세대 시퀀스 라이브러리 조제 시장 규모, 점유율, 동향 분석 리포트 : 시퀀스 유형별, 제품별, 용도별, 최종 용도별, 부문 예측(2025-2033년)

U.S. Next-generation Sequencing Library Preparation Market Summary

The U.S. next-generation sequencing library preparation market size was estimated at USD 652.2 million in 2024 and is projected to reach USD 1.96 billion by 2033, growing at a CAGR of 13.09% from 2025 to 2033. Rapid advancements in sequencing technologies and bioinformatics have facilitated the detection of DNA variations.

Additionally, the broad adoption of Next-Generation Sequencing (NGS) and Whole-Genome Sequencing (WGS) allows for the simultaneous analysis of numerous genes on a single platform, enhancing the role of DNA sequencing in clinical diagnostics. These developments are anticipated to significantly propel market growth over the forecast period.

U.S. Next-generation Sequencing Library Preparation Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. next-generation sequencing library preparation market report based on sequencing type, product, application, end use, and region:

• Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
• Targeted Genome Sequencing
• Whole Genome Sequencing
• Whole Exome Sequencing
• Other Sequencing Types
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Reagents & Consumables
  • DNA Library Preparation Kits
  • RNA Library Preparation Kits
  • Other Reagents & Consumables
• Instruments
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Drug & Biomarker Discovery
• Disease Diagnostics
  • Cancer Diagnostics
  • Reproductive Health Diagnostics
  • Infectious Disease Diagnostics
  • Other Disease Diagnostic Applications
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Sequencing Type Segment
  • 1.2.2. Product Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segmental Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. U.S. Next-generation Sequencing Library Preparation Market - Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Market Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Next-generation Sequencing Library Preparation Market: Sequencing Type Business Analysis

• 4.1. Sequencing Type Segment Dashboard
• 4.2. U.S. Next-generation Sequencing Library Preparation Market Sequencing Type Movement Analysis, 2024 & 2033
• 4.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Sequencing Type, 2021 to 2033 (USD Million)
• 4.4. Targeted Genome Sequencing
  • 4.4.1. Targeted Genome Sequencing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 4.5. Whole Genome Sequencing
  • 4.5.1. Whole Genome Sequencing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 4.6. Whole Exome Sequencing
  • 4.6.1. Whole Exome Sequencing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 4.7. Other Sequencing Types
  • 4.7.1. Other Sequencing Types Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Next-generation Sequencing Library Preparation Market: Product Business Analysis

• 5.1. Product Segment Dashboard
• 5.2. U.S. Next-generation Sequencing Library Preparation Market Product Movement Analysis, 2024 & 2033
• 5.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 5.4. Reagents & Consumables
  • 5.4.1. Reagents & Consumables Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.4.2. DNA Library Preparation Kits
    • 5.4.2.1. DNA Library Preparation Kits Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.4.3. RNA Library Preparation Kits
    • 5.4.3.1. RNA Library Preparation Kits Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 5.4.4. Other Reagents & Consumables
    • 5.4.4.1. Other Reagents & Consumables Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 5.5. Instruments
  • 5.5.1. Instruments Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Next-generation Sequencing Library Preparation Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. U.S. Next-generation Sequencing Library Preparation Market Application Movement Analysis, 2024 & 2033
• 6.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Drug & Biomarker Discovery
  • 6.4.1. Drug & Biomarker Discovery Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 6.5. Disease Diagnostics
  • 6.5.1. Disease Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Cancer Diagnostics
    • 6.5.2.1. Cancer Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. Reproductive Health Diagnostics
    • 6.5.3.1. Reproductive Health Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. Infectious Disease Diagnostics
    • 6.5.4.1. Infectious Disease Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. Other Disease Diagnostic Applications
    • 6.5.5.1. Other Disease Diagnostic Applications Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Next-generation Sequencing Library Preparation Market: End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. U.S. Next-generation Sequencing Library Preparation Market End Use Movement Analysis, 2024 & 2033
• 7.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals and Clinics
  • 7.4.1. Hospitals and Clinics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.5. Academic and Research Institutions
  • 7.5.1. Academic and Research Institutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.6. Pharmaceutical and Biotechnology Companies
  • 7.6.1. Pharmaceutical and Biotechnology Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Illumina, Inc.
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Agilent Technologies, Inc.
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. F. Hoffmann-La Roche AG, Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. BD
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Oxford Nanopore Technologies
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. New England Biolabs Inc.
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Revvity, Inc.
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. QIAGEN N.V.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Pacific Biosciences of California, Inc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Thermo Fisher Scientific Inc.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives